Grant of options
MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces that the following additional share options over the Ordinary Shares of the Company have been granted to the Executive Directors.
| Name of Director | Position | Number of share options |
| Stuart Gall | Chief Executive | 2,437,000 |
| Nicholas Sleep | Chief Technology Officer | 1,605,000 |
| Ian Whittaker | Chief Operating Officer | 1,000,000 |
| Wilson Jennings | Finance Director | 1,000,000 |
In respect of each director’s share options set out above, one third of the above share options will vest once the closing mid-market price of the Company’s Ordinary Shares reaches an average of least 25p per share for a continuous period of 20 business days; one third of the share options will vest once the closing mid-market price of the Company’s Ordinary Shares reaches an average of at least 37.5p per share for a continuous period of 20 business days and the final third of the share options will vest once the closing mid-market price of the Company’s Ordinary Shares reaches an average of at least 50p per share for a continuous period of 20 business days. Any unexercised options will lapse on 29 May 2028.The exercise price of the options is 11.25p per Ordinary Share.
Enquiries: investors.medaphor.com/advisors